Seeking Young Scientists for Research in Space
Sounds of Science Podcasts
Tackling the Inevitability of Resistance One Genome at a Time
Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
For full access to this article login to GEN Select now.
Repligen Now a Bioprocess Product Firm
One-Time Therapeutics Player Bets Future on Working as Supplier to Bioprocess Companies
- Repligen, once a strongly focused therapeutics firm, has transformed itself into a bioprocess products company in only a few years’ time. As the company’s former COO Tony J. Hunt takes the helm as president and CEO after the May retirement of Walter C. Herlihy, Ph.D., that transformation will continue ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.